Live stream preview

Next video will start in 30 seconds

Abacus CEO Jay Jackson Discusses Firm’s Future After Transfer to NYSE

Jay Jackson of Abacus speaks on the Inside the Ice House Podcast featured on NYSE Live to discuss the firm’s future after transfer to the NYSE

Replay Video
Close Open

NYSE Live Highlights

Michael Goldberg of SURGE Therapeutics Latest Milestone for Treating Cancer

5m 22s

Michael Goldberg of SURGE Therapeutics joins Ashley Mastronardi on NYSE Live to discuss latest milestone for treating cancer

Up Next in 2026

×